Menlo therapeutics inc. (MNLO)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17
TOTAL REVENUES

0

-

-

-

0

-

-

-

-

-

-

-

-

EXPENSES
Cost of goods sold

0

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration and license revenue

-

-

-

-

-

10,640

11,549

11,998

0

-

0

0

-

Collaboration and license revenue

-

-

-

-

-

-

-

-

-

-

-

-

0

Operating expenses:
Research and development

58,866

53,761

52,003

50,048

52,817

52,989

48,460

45,801

35,035

29,007

0

0

0

Selling, general and administrative

0

-

-

-

0

-

-

-

-

-

-

-

-

TOTAL EXPENSES

0

-

-

-

0

-

-

-

-

-

-

-

-

General and administrative

-

-

15,673

13,904

-

12,186

10,528

8,729

6,853

5,168

0

0

0

Total operating expenses

-

-

72,751

69,027

-

65,175

58,988

54,530

41,888

34,175

0

0

0

OPERATING LOSS

-100,247

-76,242

-68,966

-65,242

-57,199

-54,535

-45,573

-40,206

-37,258

-29,593

0

0

0

FINANCE INCOME

0

-

-

-

0

-

-

-

-

-

-

-

-

FINANCE EXPENSES

0

-

-

-

0

-

-

-

-

-

-

-

-

LOSS BEFORE INCOME TAX

0

-

-

-

0

-

-

-

-

-

-

-

-

INCOME TAX

-

-

-

-

0

-

-

-

-

-

-

-

-

Interest income and other expense, net

-

-

2,952

3,236

-

3,090

2,407

0

0

-

0

-

-

Interest income and other expense, net

-

-

-

-

-

-

-

-

-

-

-

0

0

NET LOSS FOR THE PERIOD

-98,732

-73,703

-66,130

-62,122

-53,992

-51,445

-43,128

-38,453

-36,259

-29,076

0

0

0

Other comprehensive loss:
Unrealized gain (loss) on available-for-sale securities

-

-

136

154

-

-45

-60

-127

-172

-25

0

0

0

Comprehensive loss

-

-

-69,663

-65,637

-

-51,490

-43,188

-38,580

-36,431

-29,101

0

0

0

LOSS PER SHARE BASIC AND DILUTED (in USD per share)

0.95

-2.17

-0.70

-0.69

0.47

-0.73

-0.56

-0.36

-0.72

-1.80

-1.60

-1.21

-1.08

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF BASIC AND DILUTED LOSS PER SHARE IN THOUSANDS (in shares)

42,510

15,216

23,955

23,893

32,209

23,241

22,977

22,872

17,583

5,152

5,116

5,092

5,071

Product sales
TOTAL REVENUES

0

-

-

-

-

-

-

-

-

-

-

-

-

Royalty revenues
TOTAL REVENUES

0

-

-

-

0

-

-

-

-

-

-

-

-